Pan-Tumoral Small Molecule-Drug Conjugates Targeting Fibroblasts Activation Protein in Solid Lesions

Time: 5:15 pm
day: day 1- pm


  • OncoFAP is a clinically validated small organic ligand targeting FAP in solid tumors
  • Discover how OncoFAP-drug conjugates selectively target tumors in vivo and release high amount of MMAE at the site of disease
  • Explore how OncoFAP-drug conjugates potently induce anti-tumor response at doses below tumor saturation both in monotherapy and in combination with immunotherapy